[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:post-pre-fibrotic-myelofibrosis":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"Post-Pre-Fibrotic Myelofibrosis",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06773195","A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis",[11],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:17:33.002248Z","2026-07-30T01:46:14.433209Z",[],[]]